Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

ESMO open·2024

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.

Bone marrow transplantation·2024

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019

Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells.

Leukemia·2026

Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

Leukemia·2026

Predicting long-term survival in primary myelofibrosis.

Leukemia·2026

Targeting the mitochondrial complex I subunit NDUFS2 potentiates FLT3 inhibition in acute myeloid leukaemia with FLT3 internal tandem duplication.

Leukemia·2026

Targeting the eIF4F translation initiation complex disrupts BCR::ABL1 translation and overcomes drug resistance in CML.

Leukemia·2026

Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

Leukemia·2026

Pre-transplant immunotherapy and MRD dynamics affect post-transplant prognosis in KMT2A-rearranged B-ALL patients.

Bone marrow transplantation·2026

Alloimmune risk stratification for kidney transplantation.

Kidney international·2026

A Prospective Cohort Study of Clinical Outcomes, Tear Cytokines and Proteomic Profiles Following Insular Infraorbital Neurovascular Pedicle Labial Salivary Gland Transplantation for Severe Dry Eye Disease.

Current eye research·2026

Human leukocyte antigen loss as a mechanism of immune escape after allogeneic stem cell transplantation in a patient with mycosis fungoides.

Haematologica·2026

Effects of post-transplant cyclophosphamide on immune reconstitution after haploidentical and HLA-matched transplant.

Blood advances·2026

Multidimensional Analysis of Immune Rejection in a Murine HLA-Mismatched Laryngeal Transplant Model.

The Laryngoscope·2026

Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study

Related Experiment Videos

Related Concept Videos

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells.

Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

Predicting long-term survival in primary myelofibrosis.

Targeting the mitochondrial complex I subunit NDUFS2 potentiates FLT3 inhibition in acute myeloid leukaemia with FLT3 internal tandem duplication.

Targeting the eIF4F translation initiation complex disrupts BCR::ABL1 translation and overcomes drug resistance in CML.

Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

Pre-transplant immunotherapy and MRD dynamics affect post-transplant prognosis in KMT2A-rearranged B-ALL patients.

Alloimmune risk stratification for kidney transplantation.

A Prospective Cohort Study of Clinical Outcomes, Tear Cytokines and Proteomic Profiles Following Insular Infraorbital Neurovascular Pedicle Labial Salivary Gland Transplantation for Severe Dry Eye Disease.

Human leukocyte antigen loss as a mechanism of immune escape after allogeneic stem cell transplantation in a patient with mycosis fungoides.

Effects of post-transplant cyclophosphamide on immune reconstitution after haploidentical and HLA-matched transplant.

Multidimensional Analysis of Immune Rejection in a Murine HLA-Mismatched Laryngeal Transplant Model.

Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study

Related Experiment Videos

Related Concept Videos

Related Articles